US FDA not delivering on device user fee programme, says industry
This article was originally published in RAJ Devices
Executive Summary
The US medtech industry has said that it will be hard-pressed to continue supporting the Food and Drug Administration's medical device user fee programme unless the agency demonstrates some improvement in delivering related quantitative and qualitative performance goals that will ensure the timely review of new medical devices being brought onto the market1.